 0) (N = 00). **A.** BluePrint Luminal-type indices, **B.** BluePrint HER0-type indices, **C.** BluePrint Basal-type indices, **D.** BluePrint indices comparison for the final assigned subtype (Luminal-, HER0- and or Basal-type). BluePrint subtype concordance was 00%. Each dot represents a single breast cancer sample for which total RNA underwent BluePrint microarray laboratory processing and analysis.Figure 0  